Biotech Values

[WorstLuck]

why the pps tanked on what should be extraordinary news in a small obscure biotech? I've been adding shares down to mid-.50's.

It's good news and I don't follow VXRT - but the funding only increases the value of the company to the extent that it increases the chance of getting the product approved or the company sold. Not nothing to be sure, but a company with a potential blockbuster drug trading with a market cap of 100 million tells me the price action is just that of any random microcap - i.e. it's a trading stock.

Question for this board: Anyone know of any other biotech-companies working on a pill-form-vaccine?

I have no idea. One immediate concern is that Covid and Flu vaccines (the annual vaccines where avoiding a shot plays out best) need frequent updates. Not following VXRT, could you tell me what kind of formulation changes can be made in a short period of time, per the company?